Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
- Baxter’s Accredited PD Excellence Academy Posted 09-13-2023
- Changes Afoot in Baxter and Medtronic Renal Divisions Posted 08-16-2023
- Vanderbilt Offers a One-year Fellowship Program with Home Dialysis Posted 08-16-2023
- Cannulation and PD Catheter Training Aids Posted 04-19-2023